External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes.

@article{Akimoto2004ExternalBR,
  title={External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes.},
  author={Tetsuo Akimoto and Yoshizumi Kitamoto and Jun-ichi Saito and Koichi Harashima and Takashi Nakano and Kazuto Ito and Takumi Yamamoto and Kouhei Kurokawa and Hidetoshi Yamanaka and Mitsuhiro Takahashi and Norio Mitsuhashi and Hideo Niibe},
  journal={International journal of radiation oncology, biology, physics},
  year={2004},
  volume={59 2},
  pages={372-9}
}
PURPOSE To analyze the results of clinically node-negative, localized hormone-refractory prostate cancer treated with external beam radiotherapy (EBRT) and to investigate the potential prognostic factors that influenced the therapeutic outcome. METHODS AND MATERIALS Fifty-three patients who had developed localized hormone-refractory prostate cancer were treated with EBRT between 1994 and 2001. According to the 1992 American Joint Committee on Cancer clinical stage, 4 patients had T2 and 49… CONTINUE READING

Similar Papers

Loading similar papers…